An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response - Chiaramonte,M.G.; Donaldson,D.D.; Cheever,A.W.; Wynn,T.A. (J Clin Invest, 1999)